Intrahost HIV evolution was simulated using a stochastic model of birth, death, and mutation of infected cells. Each simulation starts with a single cell infected with the origin genotype. At a birth event, an actively replicating cell gives rise to another such cell,
Despite!antiretroviral!therapy!(ART),!a!latent!reservoir!of!replication$competent!HIV$1!persists!in! resting!memory!CD4 + !T$cells!and!precludes!cure
resting!CD4 + !TScells!exists!in!an!unintegrated!state!decaying!with!a!halfSlife!of!days 8, 9 .!Another!major! population!of!infected!resting!cells!decays!with!a!halfSlife!of!weeks 10 .!The!latent!reservoir!of!integrated! proviruses,!observed!in!blood!and!lymphoid!tissue 1 ,!is!smaller!and!decays!with!halfSlife!of!~4!years 5, 6 .! Lifelong!persistence!of!this!reservoir!is!determined!by!longevity!and!proliferation!of!the!infected!cells 11 which has a chance of experiencing mutation at a random site (mutation rate u per site, sequenced DNA genome length L, HKY model-like nucleotide transition matrix with transition/transversion ratio κ and equilibrium frequencies p A , p C , p G , p T ; origin genotype shares these frequencies). An actively replicating cell is "copied" without mutation to one of the three states identified in Fig. 1 (fast- Birth rate depends on the basic reproductive ratio (R 0 ), carrying capacity (C), current number of actively replicating cells (x), and genetic fitness for sequence i (f i ). Prior to treatment, the birth rate for sequence i is
Figure!2.!Simulated!decay!of!labile!infected!cell!population!creates!misleading!appearance!of!viral! replication!and!evolution!in!first!6!months!of!treatment.!A!simulated!sample!of!50!sequences!of!length!
, where φ is the average fitness among actively replicating cells. Note that at carrying capacity (x = C), for a virus of average fitness (f i = φ), the birth rate times the burst size equals the death rate, producing equilibrium. After treatment starts (four months after the start of infection), birth rate is set to zero. If sequence i carries no lethal mutations, then its fitness is f i = exp(n p s), where n p is the number of positively-selected sites mutated in sequence i (relative to the origin) and s is the selective advantage; if the sequence carries any lethal mutations, then its fitness is zero. To account for the effect of selection outside the sequenced region (e.g., selection in env when gag is sequenced), both beneficial and lethal sites may be included in the genome outside the region of length L.
Parameter values used in all simulations: Basic reproductive ratio R 0 = 6 (peak period, first 20 days of infection), 1.4 (after peak). Death rates d = 1/day, Results summarized for each of the 50 parameter sets are shown in Supplementary 
Simulation of post-treatment decay based on sequences observed during primary infection
As proposed in the Main Text, genetic patterns observed after ART has started depend on evolutionary dynamics before ART, since pre-ART dynamics determine the relative seeding of cells of varying longevity. The results documented in Fig. 2 and Supplementary Tables 1 and 2 rely on the above model of primary infection, which makes assumptions regarding population growth, mutation, and selection. Yet the dynamics of HIV are complex, and a model is always an approximation. Here we describe our approach to sidestep this limitation by using pre-treatment sequence data.
Novitsky et al. 3 We assumed that the population at each timepoint was reported accurately by the sample. If a sample S k of sequences (some possibly redundant) were observed at time t k , we assumed that the true population at t k was composed of these sequences at equal prevalence and no others. We further assumed that the population remained unchanged until t k+1 , at which time it instantaneously changed to match sample S k+1 , based on the sequences observed at that time. We assumed that the first sequence, sampled near the time of seroconversion in all patients, represented the infection origin.
Post-ART population dynamics and simulated sampling followed the model described previously. We assumed that before ART, all viral strains contribute cells to a longer-lived compartment j at rate m j , with values given above. When ART starts, we assume all viral replication is halted, so that seeding stops. All compartments decay at a rate d j both before and after ART. The expected proportion of the simulated sample observed at time ! post-ART that matches a particular sequence present between times t k and t k+1 is then
where N k is the number of sequences sampled at t k and ! !"# is the time at which ART is started (assumed to be 4 months). Note that this formula implicitly assumes that viral load is constant throughout primary infection. Early in infection, viral load starts low, but then peaks briefly above the eventual set-point. As the early timepoints sampled likely included periods both above and below set-point viral load, we chose not to include an explicit viral peak dynamic.
Post-ART samples for each time point (0, 3, and 6 months post-ART) were constructed by random sampling of 50 pre-ART sequences with replacement, weighted by ! ! ! . 100
replicates were analyzed by the same tests of forward evolution previously described for the fully simulated data. Results of each replicate are given in Supplementary Table 3 ;
a summary is provided in Extended Data Table 1 .
